areas through its network of research-enabled Visit Centres. Every
study is assessed individually to determine the most appropriate delivery
model, infrastructure and participant pathway.
Disease Areas
Community-based research across a broad range of conditions
Supporting Research Across Diverse Therapeutic Areas
Clinical research plays a vital role in advancing understanding of diseases, treatments, diagnostics, and healthcare interventions.
Different therapeutic areas require different delivery approaches, participant pathways, and levels of clinical support.
Orizzonte’s infrastructure model is designed to support research delivery across a broad range of therapeutic areas where study requirements align with Visit Centre capability and operational feasibility.
Asthma, COPD, Cystic Fibrosis, Interstitial Lung Disease (ILD)
Hypertension, Heart Failure, Lipid Disorders
Type 2, Obesity, NAFLD, Metabolic Syndrome
Covid-19, Influenza, RSV, UTIs
Frailty, Polypharmacy, Dermentia
Eczema, Psoriasis, Acne, Contact Dermatitis
Depression, anxiety, cognitive decline
Menopause, menstrual disorders, contraception
IBS, reflux disease
(where appropriate): Asthma, allergy, vaccines
Areas of Focus
Respiratory Health
Asthma, COPD, Cystic Fibrosis, Interstitial Lung Disease (ILD)
Cardiovascular Disease
Hypertension, Heart Failure, Lipid Disorders
Metabolic Disorders
Type 2, Obesity, NAFLD, Metabolic Syndrome
Vaccines & Infectious Diseases
Covid-19, Influenza, RSV, UTIs
Multi-Morbidity & Ageing
Frailty, Polypharmacy, Dermentia
Dermatology
Eczema, Psoriasis, Acne, Contact Dermatitis
Areas of Focus
Respiratory Health
Asthma, COPD, Cystic Fibrosis, Interstitial Lung Disease (ILD)
Cardiovascular Disease
Hypertension, Heart Failure, Lipid Disorders
Metabolic Disorders
Type 2, Obesity, NAFLD, Metabolic Syndrome
Vaccines & Infectious Diseases
Covid-19, Influenza, RSV, UTIs
Multi-Morbidity & Ageing
Frailty, Polypharmacy, Dermentia
Dermatology
Eczema, Psoriasis, Acne, Contact Dermatitis
Our Therapeutic Areas
Asthma, COPD, Cystic Fibrosis, Interstitial Lung Disease (ILD)
Hypertension, Heart Failure, Lipid Disorders
Type 2, Obesity, NAFLD, Metabolic Syndrome
Covid-19, Influenza, RSV, UTIs
Frailty, Polypharmacy, Dermentia
Eczema, Psoriasis, Acne, Contact Dermatitis
Depression, anxiety, cognitive decline
Menopause, menstrual disorders, contraception
IBS, reflux disease
(where appropriate): Asthma, allergy, vaccines
Our Therapeutic Areas
Research relating to respiratory conditions, prevention strategies, and emerging treatment approaches.
Studies focused on heart and circulatory health, risk reduction, and long-term disease management.
Research involving conditions such as diabetes, weight management, and related metabolic disorders.
Studies supporting the evaluation of vaccines, prevention strategies, and infectious disease management.
Research supporting improved understanding of conditions affecting women’s health across different stages of life.
Research involving healthy participants to support the development and evaluation of new healthcare interventions.
Our Therapeutic Areas
Research relating to respiratory conditions, prevention strategies, and emerging treatment approaches.
Studies focused on heart and circulatory health, risk reduction, and long-term disease management.
Research involving conditions such as diabetes, weight management, and related metabolic disorders.
Studies supporting the evaluation of vaccines, prevention strategies, and infectious disease management.
Menopause
Menstrual disorders
Contraception
Research involving healthy participants to support the development and evaluation of new healthcare interventions.
Our Therapeutic Areas
Asthma, allergy, vaccines
Our Therapeutic Areas
Our research network supports studies across a broad range of therapeutic areas, depending on study requirements and operational feasibility.
Research into respiratory conditions, prevention and emerging treatments.
Studies focused on heart health, cardiovascular disease and prevention.
Research into diabetes, obesity and metabolic disorders.
Studies evaluating vaccines and infectious disease prevention.
Research supporting women’s health across all stages of life.
Studies involving healthy volunteers to support the development of future healthcare interventions.
Selecting the Right Delivery Model
Every study is different. Before delivery begins, we assess:
Protocol requirements
Participant populations
Clinical procedures
Infrastructure capability
Operational feasibility
This helps identify the most appropriate delivery model for each study.
Emerging Areas of Interest
Mental Health
Depression, anxiety, cognitive decline
Musculoskeletal
Osteoarthritis, chronic pain
Women’s Health
Menopause, menstrual disorders, contraception
Gastrointestinal
IBS, reflux disease
Paediatrics
(where appropriate): Asthma, allergy, vaccines
Empowering clinicians to become research-active is not just about advancing science — it’s about transforming care at its core
Dr. Aries Maximus Ogbuokiri
COO
Empowering clinicians to become research-active is not just about advancing science — it’s about transforming care at its core
Dr. Aries Maximus Ogbuokiri
COO
Who we work with
Pharmaceuticals
Hospitals
Academia
Why Our Model Works
Real-World Patient Populations:
We connect with patients in everyday settings such as GP practices, care homes, schools and community hubs to reflect real-world demographics and experiences. Our databases match individuals to studies based on medical history, interests and health profiles for relevant, impactful research.
Inclusive Recruitment
Fit-for-Purpose Sites
We connect with patients in their everyday settings such as GP practices, care homes, schools and community hubs to capture real-world demographics and lived experiences. Our recruitment databases match individuals to studies based on their medical history, interests and health profiles for truly relevant research.
We actively remove barriers to participation by engaging underserved groups and partnering with diverse community healthcare providers. This ensures trials reflect the full spectrum of patient voices and needs.
We bring research into familiar, accessible locations such as GP surgeries and community sites to improve engagement and retention. Each site is carefully chosen to meet the trial’s scientific, logistical and patient-centred requirements.
Supporting Diverse Research
Some studies are well suited to Visit Centres, while others require hospitals or specialist services. Our approach allows the delivery model to be matched to the requirements of each study, rather than applying a one-size-fits-all approach.
Who we work with
Pharmaceuticals
Hospitals
Academia
Real-World Patient Population
Inclusive Recruitment
Fit-for-Purpose Sites
Why Our Model Works
Real-World Patient Population
Inclusive Recruitment
Fit-for-Purpose Sites
Frequently Asked Questions
Research may be supported across a range of therapeutic areas depending on study requirements, infrastructure capability, and operational feasibility.
No. Suitability depends on study complexity, participant safety considerations, required procedures, and infrastructure requirements.
Studies are evaluated through feasibility assessment, operational planning, and infrastructure review before delivery pathways are determined.
Yes. Orizzonte works with Sponsors and CROs to support commercial clinical research delivery through its infrastructure model.
Research capabilities continue to evolve as the network develops and new delivery opportunities emerge.
Our Network of Partners
Who we work with
Biotechs
Pharmaceutical Industry
CROs
NHS
Discuss Your Study
Talk to our team about delivering your next study through Orizzonte’s network of research-enabled Visit Centres.